Mosapride (5HT4 agonist) in the treatment of blepharospasm

dc.contributor.authorPiyasena, I.N.A.P.
dc.contributor.authorJayasinghe, J.A.C.
dc.date.accessioned2016-01-19T05:53:43Z
dc.date.available2016-01-19T05:53:43Z
dc.date.issued2014
dc.identifier.citationThe Ceylon Medical Journal, 59(1):p.26-27
dc.identifier.urihttps://dl.nsf.gov.lk/handle/1/21998
dc.publisherThe Sri Lanka Medical Association:Colombo
dc.subjectMedical Sciences
dc.subjectBlepharospasm
dc.subjectMosapride
dc.subject5HT4 agonist
dc.subjectBotulinum toxin
dc.titleMosapride (5HT4 agonist) in the treatment of blepharospasm
dc.typeArticle

Files